PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	3-hydroxy-2-methyl-4H-pyran-4-thione	45-48	pro-opiomelanocortin-alpha	Mus musculus	191-200	
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	3-hydroxy-2-methyl-4H-pyran-4-thione	45-48	Norrie disease (pseudoglioma) (human)	Mus musculus	205-208	
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	3-hydroxy-2-methyl-4H-pyran-4-thione	45-48	msh homeobox 1	Mus musculus	197-200	
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	tm6	59-62	pro-opiomelanocortin-alpha	Mus musculus	191-200	
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	tm6	59-62	Norrie disease (pseudoglioma) (human)	Mus musculus	205-208	
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	tm6	59-62	msh homeobox 1	Mus musculus	197-200	
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	Phenylalanine	23-26	pro-opiomelanocortin-alpha	Mus musculus	191-200	
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	Phenylalanine	23-26	Norrie disease (pseudoglioma) (human)	Mus musculus	205-208	
11352754-6	2001	We have identified the Phe176 (TM4), Tyr179 (TM4), Phe254 (TM6), and Phe259 (TM6) receptor residues as putatively interacting with the melanocortin-based ligand Phe(7) by differences between alpha-MSH and NDP-MSH agonist potencies.	Phenylalanine	23-26	msh homeobox 1	Mus musculus	197-200	
11352754-11	2001	Melanocortin-based peptides modified at the 7 position of MTII with DPhe, DNal(1"), Nal(2"), and DNal(2") have been pharmacologically characterized at these mutant mouse MC4Rs.	D-phenylalanine	68-72	metallothionein 2	Mus musculus	58-62	
11352754-12	2001	These data suggest a revised hypothesis for the mechanism of SHU9119 antagonism at the MC4R which may be attributed to the presence of a "bulky" naphthyl moiety at the 7 position (original hypothesis), and additionally that both the stereochemistry and naphthyl ring position (2" versus 1") are important for positioning of the ligand Arg(8) residue with the corresponding mMC4R amino acids.	Arginine	335-338	melanocortin 4 receptor	Mus musculus	87-91